Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current leishmaniasis drug discovery
Alessandra C. Pinheiro, M.V.N. De Souza
RSC Medicinal Chemistry (2022) Vol. 13, Iss. 9, pp. 1029-1043
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Global Health Priority Box: Discovering Flucofuron as a Promising Antikinetoplastid Compound
Carlos J. Bethencourt-Estrella, Atteneri López‐Arencibia, Jacob Lorenzo‐Morales, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 554-554
Open Access | Times Cited: 4
A Novel Colorimetric Assay for Early Differentiation of Mucocutaneous and Cutaneous Leishmaniasis Via Species-Specific Identification
Nancy Villegas Villao, Mavys Tabraue-Chávez, Cristina Megino-Luque, et al.
(2025)
Closed Access
Targeting Cysteine Protease B to Discover Antileishmanial Drugs: Directions and Advances
Esteban F. Rios, Sonaly Lima Albino, Ricardo Olímpio de Moura, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117500-117500
Closed Access
A Novel Colorimetric Assay for Early Differentiation of Mucocutaneous and Cutaneous Leishmaniasis via Species-Specific Identification
Nancy V. Villegas, Mavys Tabraue-Chávez, Cristina Megino‐Luque, et al.
Talanta (2025), pp. 128016-128016
Closed Access
Promising Antiparasitic Natural and Synthetic Products from Marine Invertebrates and Microorganisms
Mingyue Zhang, Qinrong Zhang, Qunde Zhang, et al.
Marine Drugs (2023) Vol. 21, Iss. 2, pp. 84-84
Open Access | Times Cited: 10
Gold(I) and Silver(I) Complexes Containing Hybrid Sulfonamide/Thiourea Ligands as Potential Leishmanicidal Agents
Alice P. Borges, Malú Mateus Santos Obata, Silvia H. Libardi, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 452-452
Open Access | Times Cited: 3
Leishmaniasis y su Resistencia a Fármacos: Un Enfoque Bibliométrico
César Aníbal Barzola Gaibor
Estudios y Perspectivas Revista Científica y Académica (2025) Vol. 4, Iss. 4, pp. 2464-2512
Closed Access
A Novel Colorimetric Assay for Early Differentiation of Mucocutaneous and Cutaneous Leishmaniasis Via Species-Specific Identification
Nancy Villegas Villaoa, Mavys Tabraue-Chávez, Cristina Megino-Luque, et al.
(2025)
Closed Access
Recent developments in the treatment of leishmaniasis: Natural compounds, drug targets, in silico molecular docking approaches, and nanocarriers
Nergiz Gürbüz Çolak
Studies in natural products chemistry (2025), pp. 461-494
Closed Access
Antiparasitic and Antifungal Activities of Cetyl-Maritima, a New N-Cetyl-Modified Maritima Derivative
Ibrahim S. Al Nasr, Jingyi Ma, Tariq A. Khan, et al.
Antibiotics (2025) Vol. 14, Iss. 3, pp. 321-321
Open Access
hsa-miR-330-5p regulates serine palmitoyltransferase long chain base subunit 1 and augments host protective immune response against Leishmania donovani infection
Sajjadul Kadir Akand, Areeba Rahman, Mohammad Masood, et al.
Archives of Microbiology (2025) Vol. 207, Iss. 6
Closed Access
Field-Deployable Treatments For Leishmaniasis: Intrinsic Challenges, Recent Developments and Next Steps
Thalia Pacheco‐Fernández, Hannah L. Markle, Chaitenya Verma, et al.
Research and Reports in Tropical Medicine (2023) Vol. Volume 14, pp. 61-85
Open Access | Times Cited: 9
Synthesis and Biophysical and Biological Studies of N-Phenylbenzamide Derivatives Targeting Kinetoplastid Parasites
J. Jonathan Nué-Martínez, David Cisneros, María del Valle Moreno-Blázquez, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 19, pp. 13452-13480
Open Access | Times Cited: 8
Experimental structure based drug design (SBDD) applications for anti‐leishmanial drugs: A paradigm shift?
Miguel Marín, M. Allué López, Laura Gallego‐Yerga, et al.
Medicinal Research Reviews (2023) Vol. 44, Iss. 3, pp. 1055-1120
Open Access | Times Cited: 8
Biomedical Applications of Green Synthesized Zinc Oxide and Magnesium-Doped Zinc Oxide Nanoparticles Using Aqueous Extract of Ziziphus Oxyphylla Leaves
Suliman Syed, Arshad Islam, Muhammad Shabeer, et al.
IEEE Transactions on NanoBioscience (2024) Vol. 23, Iss. 3, pp. 418-427
Closed Access | Times Cited: 2
Phytochemical profiling and in silico evaluation of Artemisia absinthium compounds targeting Leishmania N-myristoyltransferase: molecular docking, drug-likeness, and toxicity analyses
Farouk Boudou, Amal Belakredar, A. Adda Berkane, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 2
Rational repurposing, synthesis, in vitro and in silico studies of chromone-peptidyl hybrids as potential agents against Leishmania donovani
Ahmed H.E. Hassan, Waleed A. Bayoumi, Selwan M. El‐Sayed, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 5
Leishmania Vesicle-Depleted Exoproteome: What, Why, and How?
Sofia Esteves, Inês Costa, Sara Luelmo, et al.
Microorganisms (2022) Vol. 10, Iss. 12, pp. 2435-2435
Open Access | Times Cited: 8
Physical-chemical repurposing of drugs. History of its formation in Russia
Aleksandr Urakov, Петр Д. Шабанов
Reviews on Clinical Pharmacology and Drug Therapy (2023) Vol. 21, Iss. 3, pp. 231-242
Closed Access | Times Cited: 4
Design, Synthesis, and Repurposing of Rosmarinic Acid-β-Amino-α-Ketoamide Hybrids as Antileishmanial Agents
Ahmed H.E. Hassan, Waleed A. Bayoumi, Selwan M. El‐Sayed, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1594-1594
Open Access | Times Cited: 4
Hit-to-lead optimization of 2-aminoquinazolines as anti-microbial agents against Leishmania donovani
Nirmal K. Das, Jayasree Roy, Binita Patra, et al.
European Journal of Medicinal Chemistry (2024) Vol. 269, pp. 116256-116256
Closed Access | Times Cited: 1
Synthesis, biological evaluation and mechanism of action of benzothiazole derivatives with aromatic hydrazone moiety, a new class of antileishmanial compounds
Elaine Soares Coimbra, Luciana Maria Ribeiro Antinarelli, Ari Sérgio de Oliveira Lemos, et al.
Chemical Biology & Drug Design (2024) Vol. 104, Iss. 1
Closed Access | Times Cited: 1
Investigation new drugs for the treatment of leishmaniasis
Shyam Sundar, Vishal Singh, Neha Agrawal, et al.
Expert Opinion on Investigational Drugs (2024), pp. 1-18
Closed Access | Times Cited: 1
Holanamine, a Steroidal Alkaloid from the Bark of Holarrhena pubescens Wall. ex G. Don Inhibits the Growth of Leishmania donovani by Targeting DNA Topoisomerase 1B
Narender Goel, Vivek Gupta, Aakriti Garg, et al.
ACS Infectious Diseases (2022) Vol. 9, Iss. 1, pp. 162-177
Closed Access | Times Cited: 4
A QSAR Study for Antileishmanial 2-Phenyl-2,3-dihydrobenzofurans †
Freddy A. Bernal, Thomas J. Schmidt
Molecules (2023) Vol. 28, Iss. 8, pp. 3399-3399
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top